DV
Dividend Vision

PHAT — Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. (PHAT)

Total return is -61.1% over the past 6.8 years, 244.9 points behind SPY at 183.8%. Its deepest 1-year drawdown was 54.5%.

PHAT is a healthcare equity stock that tracks Phathom Pharmaceuticals, Inc., a single-company holding rather than a diversified fund. The fund does not currently pay distributions, making it unsuitable for income-focused investors seeking dividend yield. This holding appeals primarily to growth-oriented investors interested in gaining exposure to the pharmaceutical sector through a concentrated position in a single company.

PHAT key facts

Asset type
Stock
Asset class
Equity
Inception date
10/25/2019
Distribution frequency
None
Last close
$9.58
Market cap
$742,670,592
Average volume
969080.0
Beta
0.499
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.25